Funding round brings in $6.4M for developer of Alzheimer's drug

05/7/2013 | MedCityNews.com

NeuroPhage Pharmaceuticals secured $6.4 million in a funding round led by Mérieux Développement. The company will use the proceeds to advance development of its potential Alzheimer's drug NPT002, which is in preclinical development. The firm plans to submit an investigational new drug application and begin clinical trials next year.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC